Hey there! Welcome!
Get updated on
Select Speciality
Top Picks
18 Nov, 26
HF & CKD are interlinked; ESC 2026 CVD-CKD Guidelines focus on the need of integrated management of CVD-CKD. Routine eGFR/UACR screening, GDMT & proactive hyperkalemia management may improve survival, cut hospitalizations, & preserve renal function.
13 Nov, 26
AHA 2026
The sessions presented at AHA 2026, underscore the importance of secondary prevention in MI patients and focus on the benefits of beta-blocker treatment and reperfusion treatment in these patients.
20 Nov, 26
Int Dent J.
- In a meta-analysis of 30 studies (2,476 BMS patients; 2,417 controls), burning mouth syndrome (BMS) was associated with significantly higher anxiety (SMD 1.12), depression (SMD 1.12), & sleep disturbance (SMD 0.97; all p<0.001)
- OHRQoL was also markedly impaired (MD 16.04; p<0.001)
- Findings support multidisciplinary management of both pain & psychological comorbidities.
20 Nov, 26
Diabetes Care.
- The UK CF Registry analysis included 4,477 CF-related diabetes patients (31,311 person-yrs of follow-up, & 758 deaths)
- Compared with HbA1c ≤42 mmol/mol, adjusted mortality rate ratios were 1.41 for >42–53 mmol/mol, 1.66 for >53–69 mmol/mol, & 1.93 for >69 mmol/mol
- Higher long-term HbA1c was associated with a progressive, clinically significant increase in mortality risk in CF-related diabetes.
19 Nov, 26
Diabetes Obes Metab.
- Amongst 833 adults with hypertension (HTN) &/or diabetes (DM), attending tertiary clinic in India, clinical obesity was prevalent in 70.7%, highest in HTN alone (88%)
- BMI & Conicity Index were significantly elevated (p<0.001), age 60-69 yrs, extended family status, HTN >10 yrs, tobacco use, & coexisting HTN+DM independently increased obesity risk (p<0.001)
- Sensitivity analysis estimated obesity prevalence at 50%
17 Nov, 26
Eur J Prev Cardiol.
- Elevated remnant cholesterol [≥1 mmol/L (39 mg/dL)] was more prevalent in familial hypercholesterolemia (FH) population (12%-78%) vs non-FH individuals (11%-12%)
- Across CGPS & UK Biobank, remnant cholesterol ≥1 mmol/L was associated with higher CAD risk in FH (HRs 1.14-1.60) & non-FH subjects (HR 1.47-1.49), conferring an approximately 50% additional CAD risk beyond lifelong LDL-C elevation in FH individuals.
Featured

12 Nov, 26

26 Oct, 26

26 Oct, 26






















